Verification evidence is still being completed.
PDF / print export
URPL Poland
Warsaw, Poland
- Verified lead
- Grzegorz Cessak
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President
- 2026 technical specialization
- Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance
- Review cycle
- May 2026
- Full address
- Al. Jerozolimskie 181C, 02-222 Warszawa, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- URPL president disclosure.
- Editorial note
- National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.
Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance
National registration authority, EU medicines and devices regulatory enforcement
National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.
- Lead
- Grzegorz Cessak (verified ↗)
- Address
- Al. Jerozolimskie 181C, 02-222 Warszawa, Poland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- National registration authority
- Capabilities
- Registration of medicinal products · Medical-device oversight · Biocidal product regulation
- Founded
- 2002
- Headcount
- 201-500
Clinical profileSTATUS: VERIFIED MARCH 2026
Grzegorz Cessak
President
Full addressAl. Jerozolimskie 181C, 02-222 Warszawa, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
National registration authority
Warsaw, Poland. Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance. Review completed on 15 Mar 2026.
Polish Ministry of Health and EU medicines regulatory framework
National registration authority, EU medicines and devices regulatory enforcement
Medicines Registration, Medical Device Oversight, Biocidal Regulation, and Pharmacovigilance
National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access.
Related companies
Editorial note
URPL anchors the Polish regulatory layer for approvals, market access, vigilance, and regulated product governance.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Registration of medicinal products
Medical-device oversight
Biocidal product regulation
Post-market vigilance
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Registration offices
Assessment teams
Vigilance and device supervision systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is URPL Poland located?
- URPL Poland operates from Al. Jerozolimskie 181C, 02-222 Warszawa, Poland, Warsaw, Poland.
- Who runs URPL Poland?
- URPL Poland is led by Grzegorz Cessak, President. Verified 15 Mar 2026.
- What does URPL Poland do?
- National registration and surveillance authority shaping Polish medicines, devices, and biocidal-product market access. Core capabilities: Registration of medicinal products, Medical-device oversight, Biocidal product regulation, Post-market vigilance.
Editorial context
Related technical briefs
Briefs that name Warsaw as a covered market or city.